Tradable Biotech Stocks Events For the Second Quarter
at The Street - Thu Apr 03, 8:00AM CDT
The biotech sector's March "fluctuation" might be a temporary speed bump or the beginning of a longer downturn. Either way, investors can still count on the biotech catalyst trade for chills and thrills.
Foundation Medicine and Clovis Oncology Expand Collaboration to Develop Novel Companion Diagnostic for Rucaparib in Ovarian Cancer
Business Wire - Thu Apr 03, 5:30AM CDT
Foundation Medicine, Inc. (NASDAQ: FMI) and Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the expansion of their ongoing collaboration to incorporate a coordinated regulatory strategy for the development of a novel Premarket Approval (PMA) companion diagnostic test. This test is designed for use by physicians to identify patients most likely to respond to rucaparib, Clovis' poly (ADP-ribose) polymerase (PARP) inhibitor currently the subject of Phase 2 and Phase 3 clinical trials in patients with ovarian cancer.
Biggest Biotech Clinical Wins of the Week
Cory Renauer, The Motley Fool - Motley Fool - Mon Mar 31, 1:30PM CDT
Last week was full of great news for biotechs. Idera Pharmaceuticals finally had some luck with a troubled program. Clovis Oncology took a big step toward treating defined populations with unmet need with a drug and diagnostic combination....
Nasdaq stocks posting largest percentage decreases
AP - Fri Mar 28, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Citigroup and GameStop are big market movers
AP - Thu Mar 27, 3:40PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
4 Stocks Triggering Breakouts on Unusual Volume
at The Street - Thu Mar 27, 8:15AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
Morning Movers in Biotech: Clovis Oncology, Inc., Exact Sciences Corporation, GlaxoSmithKline PLC, a
George Budwell, The Motley Fool - Motley Fool - Thu Mar 27, 8:00AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a look at the top stories in biotech and health...
Clovis Oncology's CO-1686 Demonstrates Compelling Clinical Activity and Progression-free Survival (PFS) in Updated Phase 1 Study Results in Patients with Non-small Cell Lung Cancer (NSCLC)
Business Wire - Thu Mar 27, 4:00AM CDT
--PFS greater than six months in heavily-pretreated T790M+ patient population; median not yet reached
Better Buy: Clovis Oncology, Inc. or Endocyte, Inc?
George Budwell, The Motley Fool - Motley Fool - Mon Mar 24, 5:00PM CDT
Biotechs developing treatments for diseases with few therapeutic options can perform well in a variety of situations. This is especially true for developmental stage oncology companies because of the strong demand for new treatments. Indeed, ...
'Fast Money' Recap: China Syndrome
at The Street - Thu Mar 06, 4:00AM CST
The trading panel discussed how to invest in and around China.
Why Clovis Oncology, Inc. Shares Jumped
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 28, 12:21PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Clovis Oncology , a clinical-stage...
Wood Resources International LLC: China imported logs and lumber for a record nine billion dollars in 2013, with North America, Russia and New Zealand being the major suppliers
Business Wire - Fri Feb 28, 2:45AM CST
Importation of logs and lumber to China reached a new record in 2013 with lumber imports being up 19% and log imports increasing 23% from 2012, as reported in the Wood Resource Quarterly. North America, Russia and New Zealand were the major supplying countries but Sweden, Finland, Ukraine, Chile and Australia saw the biggest increases in market share
Clovis Oncology Announces 2013 Operating Results and Expands CO-1686 Development Program
Business Wire - Thu Feb 27, 3:02PM CST
--Potential to accelerate NDA submission timeline
Research and Markets: China Polyaniline (PAN) Market 2014 Report
Business Wire - Tue Feb 25, 6:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/6s8blr/research_and) has announced the addition of the "Research and Investment Prospect Evaluation of China Polyaniline (PAN) Market, 2014" report to their offering.
Clovis Oncology to Announce Fourth Quarter/Year End 2013 Financial Results and Host Webcast Conference Call on February 27
GlobeNewswire - Tue Feb 18, 3:05PM CST
Clovis Oncology, Inc. (Nasdaq:CLVS) will announce its fourth quarter/year end 2013 financial results on Thursday, February 27, 2014, after the close of the U.S. financial markets. Clovis' senior management will host a conference call and live audio webcast on Thursday, February 27, at 4:30 p.m. ET to discuss the company's results in greater detail.
Commit To Purchase Clovis Oncology At $50, Earn 20.8% Annualized Using Options
at The Street - Tue Feb 18, 10:26AM CST
Investors eyeing a purchase of Clovis Oncology shares, but tentative about paying the going market price of $69.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...
Nexstim Announces New Stroke Therapy Produced Significant Gains in Motor Function Post-Stroke
Business Wire - Fri Feb 14, 7:50AM CST
Every two seconds someone in the world suffers a stroke. A study from the Rehabilitation Institute of Chicago approached stroke rehabilitation through a new combination of therapies which produced significantly greater gains in patients' motor function 6 months post-stroke. The combination of non-invasive navigated transcranial stimulation (nTMS) along with occupational therapy (OT) opened the door to improving the quality of life for stroke survivors. The study presented Thursday at the American Heart Association (AHA) and the American Stroke Association's (ASA) International Stroke Conference, yielded results from the active group of improved function by 13+ points in UEFM score.
Critical Alerts For 3D Systems, JA Solar, Apollo Group, Illumina, and Clovis Oncology Released By InvestorsObserver
PR Newswire - Thu Feb 13, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for DDD, JASO, APOL, ILMN, and CLVS.
Clovis Oncology to Present at the 2014 Leerink Global Healthcare Conference
Business Wire - Thu Feb 06, 7:00AM CST
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, the Company's president and CEO, will present at the 2014 Leerink Global Healthcare Conference on Thursday, February 13, at 11:25am MST. The conference is being held at the Waldorf Astoria in New York City.